Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Regulatory review of drugs and devices: Worksharing with other international regulatory authorities - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 256426
Later capture
Regulatory review of drugs and devices: Worksharing with other international regulatory authorities - Canada.ca
Jan 2, 2026
hc-20260101
ID 428616
updated2 sections changed
2 sections changed0 added0 removed+0 / -3 linesChange ratio: 11%
--- +++ @@ -1,6 +1,4 @@ Worksharing with other international regulatory authorities-From:-Health Canada This project will create a streamlined process for joint reviews between Health Canada and other international regulatory authorities. It will build on our existing relationships with the Australia-Canada-Singapore-Switzerland (ACSS) Consortium. Lessons learned in this worksharing arrangement will help to develop a worksharing framework. This may expand to other national regulatory authorities interested in partnering. We expect this project to strengthen our partnerships. Partnering in submission reviews will help Canadians gain greater access to new health products that meet health care system needs. This includes drugs for rare diseases.@@ -11,5 +9,4 @@ implementation plan (2020) We expect that all parts of this project will be fully in place by fall 2020. Page details-Date modified: 2018-02-16